Joint Accreditation Committee - ISCT - EBMT, also known as JACIE, is a non-profit body established in Europe for the purpose of accrediting providers of cell therapy. The JACIE standards currently apply only to stem cells derived from blood sources such as bone marrow, peripheral blood, and umbilical cord blood. The primary scope of JACIE accreditation is the use of blood-forming stem cells (known as Hematopoietic Stem Cells or HSC) and Therapeutic Cells (TC) to be used for blood diseases and cancers. There is a broader scope for their accredited laboratories, which may or may not include other types of blood-derived cells. The list of JACIE accredited centres can be downloaded.
JACIE was founded in 1998 by two professional societies: the International Society for Cellular Therapy (ISCT) and the European Group for Blood and Marrow Transplantation (EBMT). Since 2002 JACIE has also collaborated with the Foundation for the Accreditation of Cellular Therapy (FACT) to create international standards for providing cell therapy products.
JACIE's stated mission is to promote high quality patient care and laboratory performance through an internationally recognized system of accreditation. JACIE does not accredit cord blood banks. Their accreditation program focuses on transplant centers that administer cord blood (and other blood-derived cells) to patients. The scope of JACIE accreditation for the clinical use of cord blood is the same as FACT accreditation, particularly the end-to-end coverage of both laboratory practices and clinical care. However, their accreditation programs are administered separately.
JACIE's stated mission is to promote high quality patient care and laboratory performance through an internationally recognized system of accreditation. JACIE does not accredit cord blood banks. Their accreditation program focuses on transplant centers that administer cord blood (and other blood-derived cells) to patients. The scope of JACIE accreditation for the clinical use of cord blood is the same as FACT accreditation, particularly the end-to-end coverage of both laboratory practices and clinical care. However, their accreditation programs are administered separately.
The JACIE Accreditation Programme was recognized in 2011 by the European Commission under the Public Health Programme as an exemplary project. In January 2012, JACIE launched a survey of the different national regulations relevant to the JACIE Standards, and data for 9 nations has been reported as of summer 2012.